The deal secures two sleep disorder drugs that would fill a hole in the company’s portfolio and intensify a competition with ...

Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold for the next 3 years. On March 31, Eli Lilly ...

Social media is awash with chemical compounds you can’t pronounce promising the world. When it comes to self-dosing mushrooms ...

Alkermes plc (Nasdaq: ALKS) today announced the initiation of the Brilliance Studies, a phase 3 program evaluating the safety ...

Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal valued at up to $7.8 billion as the U.S. drugmaker ...

Indianapolis-based Eli Lilly and Co. announced plans to acquire UK-based Centessa Pharmaceuticals in a deal worth up to $7.8 ...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...

Millions of people start work before sunrise—but their brains aren’t ready for it. A new clinical trial has found that the ...

Eli Lilly agreed to buy Centessa Pharmaceuticals in a deal valued at about $6.3 billion upfront, with total consideration ...

Eli Lilly agreed to acquire Centessa Pharmaceuticals for approximately $7.8 billion, expanding its neuroscience pipeline. Eli ...

The involving Centessa Pharmaceuticals marks a notable step in expanding therapeutic reach into neuroscience. This move ...

Eli Lilly rises after $7.8 billion Centessa deal to expand sleep drugs. Centessa ADR jumps 45% as Lilly bets on orexin ...